Core Insights - Investing in dividend-paying stocks is an effective way to generate passive income, with Healthpeak Properties, Realty Income, and Stag Industrial highlighted as top choices for monthly dividends [1] Group 1: Healthpeak Properties - Healthpeak Properties is a REIT focused on the healthcare sector, leasing properties such as outpatient medical buildings and senior housing, providing stable rental income [3] - The company switched to a monthly dividend schedule in April, currently paying $0.10167 per share monthly, equating to an annual payout of $1.22, resulting in a yield of over 7% [4] - Healthpeak's latest dividend rate is 2% higher than in 2024, with an estimated financial flexibility of $500 million to $1 billion for future investments or share repurchases [5] Group 2: Realty Income - Realty Income, known as "The Monthly Dividend Company," declared its 659th consecutive monthly dividend in May, with a payout of $0.2685 per share in mid-June, yielding nearly 6% [6][7] - The company has raised its dividend 130 times since its public listing in 1994, maintaining a consistent increase for the past 110 quarters [8] - Realty Income plans to invest around $4 billion this year, supported by a low payout ratio of 75% of adjusted FFO, allowing for continued portfolio and payout growth [9] Group 3: Stag Industrial - Stag Industrial owns a diversified portfolio of industrial properties, paying about two-thirds of its cash flow in dividends, which allows for over $100 million annually for new investments [10] - The next monthly dividend of $0.12167 per share will be paid on July 15, providing a yield of over 4% at the current share price [10] - Stag Industrial plans to invest between $350 million and $650 million into new properties this year, focusing on stabilized properties and those with redevelopment potential [11] Group 4: Summary of Investment Opportunities - Healthpeak Properties, Realty Income, and Stag Industrial are identified as high-yielding monthly dividend stocks with potential for future growth, making them attractive options for passive income seekers [12]

Group 1 - The iREIT® Tracker provides comprehensive data on over 250 tickers, including quality scores, buy targets, and trim targets, focusing on REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, Builders, and Asset Managers [1] - The investment group iREIT®+HOYA Capital is led by experienced analysts with a combined 100+ years in the industry, including backgrounds in hedge funds, due diligence, and military service [1] - Brad Thomas has over 30 years of experience in real estate investing, having been involved in over $1 billion in commercial real estate transactions [2]

Group 1 - The specialized life science sector has significant demand due to approximately 10,000 known diseases, with over 90% lacking approved treatments [1] - iREIT®+HOYA Capital focuses on various income-oriented investment alternatives, including REITs, BDCs, and MLPs, supported by a team with over 100 years of combined experience [2] - Brad Thomas, a prominent figure in real estate investing, has a track record of over $1 billion in commercial real estate transactions and has been featured in major media outlets [3]

Core Viewpoint - Real estate investment trusts (REITs) can provide significant dividend yields, with AGNC Investment and Healthpeak Properties being highlighted for their monthly dividends, but their sustainability and growth potential differ significantly [1]. Group 1: AGNC Investment - AGNC Investment is a mortgage REIT that invests in Agency MBS, which are protected against credit risk by government agencies, and it employs leverage to enhance returns, resulting in a high monthly dividend yield of 15.7% [3]. - The CEO noted that the outlook for agency MBS investments remains favorable, with potential returns in the low-20% range, which exceeds the company's total cost of capital of approximately 18% [4]. - However, AGNC has previously cut its dividend when returns fell below costs, indicating that it may not be the best option for investors seeking a highly sustainable income stream [5]. Group 2: Healthpeak Properties - Healthpeak Properties is a healthcare REIT with a diversified portfolio that includes outpatient medical, lab, and senior housing properties, providing stable cash flow with contractual annual rental increases [7]. - The REIT's adjusted funds from operations (FFO) have grown by 19% over the past three years, and it expects to generate between $1.81 and $1.87 per share of FFO this year, comfortably covering its $1.22-per-share dividend [9]. - Healthpeak has a strong balance sheet with $500 million to $1 billion available for new investments, and it recently raised its dividend payout by 2%, indicating a capacity for future dividend increases [10][12].

Group 1: Passive Income through REITs - Investing in real estate investment trusts (REITs) with high dividend yields can generate significant passive income, with an example showing an investment of $11,250 yielding over $1,000 annually [1] - The selected REITs include AGNC Investment, Realty Income, Healthpeak Properties, and EPR Properties, all of which pay monthly dividends, making them suitable for regular income [1][13] Group 2: AGNC Investment - AGNC Investment is a mortgage REIT that invests in residential mortgage-backed securities (MBS) backed by government agencies, making it a low-risk investment [2] - The company employs leverage to enhance returns, with potential returns in the low 20% range, sufficient to cover dividends and operating expenses [4] - AGNC has a higher risk profile due to market condition fluctuations that could affect returns and dividend maintenance [5] Group 3: Realty Income - Realty Income is known for its reliability, having declared its 659th consecutive monthly dividend and increased payments for 110 straight quarters, with a 4.3% compound annual growth rate [6][8] - The REIT's diversified portfolio of net lease properties provides stable rental income, as tenants cover all operating expenses [7] Group 4: Healthpeak Properties - Healthpeak Properties focuses on healthcare real estate, owning outpatient medical, lab, and senior housing properties, benefiting from the aging U.S. population [9][10] - The company has a strong financial profile, allowing for new investments, with $500 million to $1 billion available for expansion [10] Group 5: EPR Properties - EPR Properties specializes in experiential real estate, including movie theaters and fitness venues, generating steady rental income through net leases [11] - The REIT plans to invest $200 million to $300 million annually in new properties, with projects lined up to drive 3% to 4% annual cash flow growth [12]

Summary of Healthpeak Properties Conference Call Company Overview - Healthpeak Properties is a real estate investment trust (REIT) with a market capitalization of approximately $25 billion, focusing on healthcare real estate, primarily in outpatient medical facilities (60% of business), senior housing (10%), and life sciences/lab facilities (30%) [2][3] Core Business Insights - Healthpeak is the largest owner of outpatient medical facilities globally and the second or third largest owner of lab life sciences facilities [2][3] - The company has a strong tenant base, with HCA (largest for-profit health system) and CommonSpirit (largest non-profit health system) as significant tenants [4][5] - Healthpeak has demonstrated resilience during the pandemic, collecting 99% of rent and maintaining occupancy rates [7][8] Market Dynamics - The outpatient medical sector is experiencing consistent growth due to demographic trends, with 12,000 people turning 65 daily, leading to increased demand for healthcare services [12][35] - The average rent for outpatient medical space is approximately $23 per square foot, while new construction costs are significantly higher at $35 to $40 per square foot, making existing properties more attractive [13][15] - Healthpeak's outpatient medical facilities are strategically located in fast-growing markets such as Atlanta, Dallas, and Phoenix [10] Lab Space Insights - The lab real estate market has seen a temporary oversupply due to increased construction during the pandemic, leading to challenges in recruiting new tenants [22][24] - Healthpeak operates in key markets like Boston, South San Francisco, and San Diego, where demand for lab space remains strong despite current oversupply [18][22] - The company emphasizes the importance of collaboration in lab environments, providing amenities that facilitate interaction among scientists [19][20] Financial Performance and Growth - Healthpeak offers a 7% dividend based on its current stock price, with a payout ratio of 70% of cash flow [24] - The company is focused on leasing the remaining 15% of its lab space, which could generate an additional $60 to $75 million in annual rent [43] - Future growth is anticipated from the aging population and the increasing shift of healthcare services to outpatient settings [35][36] Regulatory and Funding Environment - The company is monitoring NIH funding and its impact on the lab space, noting that while direct funding remains stable, the overall capital markets have slowed down [37][40] - Healthpeak is strategically investing in "zombie buildings" through loans to capitalize on future demand once the market stabilizes [44][32] Conclusion - Healthpeak Properties is well-positioned for growth in both outpatient medical and lab spaces, leveraging demographic trends and strategic partnerships with health systems. The company remains resilient in the face of market challenges and is focused on long-term growth opportunities in the healthcare real estate sector [46][47]

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

Financial Data and Key Metrics Changes - The company reported FFOs adjusted of $0.46 per share and AFFO of $0.43 per share, with total portfolio same-store growth of 7% [29] - The company maintained its FFO as adjusted guidance in the range of $1.81 to $1.87 per share, reflecting strong performance during the first quarter [32] Business Line Data and Key Metrics Changes - Outpatient Medical reported same-store growth of 5%, driven by strong tenant retention and a positive rent mark to market of 4.1% [29] - The Lab business reported same-store growth of 7.7%, benefiting from the expiration of pre-rent on two large leases [30] - Continuing Care Retirement Communities (CCRCs) reported same-store growth of 15.9%, driven by rate growth of approximately 6% and a 100 basis point increase in occupancy [31] Market Data and Key Metrics Changes - The outpatient sector is experiencing demand outpacing new supply, a trend expected to continue due to high construction costs [12] - The Lab business represents approximately 35% of the company's income, facing challenges due to regulatory uncertainties and capital raising difficulties in the biotech sector [14] Company Strategy and Development Direction - The company is focusing on capturing market share with its high-quality portfolio, having signed 450,000 square feet of leases year-to-date [21] - The merger with Physicians Realty Trust has increased the allocation to the outpatient medical business to over 50%, improving the balance sheet and creating a strong platform in the outpatient sector [23] - The company has paused new developments since 2021 and is reassessing capital allocation strategies in light of market uncertainties [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the diversified portfolio's ability to maintain guidance despite market challenges, with strong results in Outpatient Medical and Senior Housing offsetting weaknesses in the Lab business [11] - The management noted that the first quarter was not ideal for capital raising in the biotech sector, but they see potential inflection points that could stabilize the market [36][38] Other Important Information - The company has reduced floating rate debt from 20% to almost zero, positioning its balance sheet favorably for long-term success [22] - The partnership with Hines for the West Cambridge development project is expected to advance the residential component, with no construction cost exposure for Healthpeak [28][124] Q&A Session Summary Question: What would change to a more positive expectation for life science performance in the back half of 2025? - Management indicated that stability in the market and regulatory environment would benefit the sector, with potential upside from patent cliffs and capital raising [36][38] Question: Were the share repurchases driven by stock attractiveness or underwriting difficulties? - The share repurchases were primarily driven by the attractiveness of the stock, with nearly $100 million bought back at a high-quality portfolio yield [47] Question: How is the health of the tenant base in the lab business? - There has been significant improvement in rent collections and bad debt, but uncertainty remains regarding tenants needing to raise capital [55] Question: What is the outlook for leasing activity in the lab sector? - The leasing pipeline is strong, with many tenants well-capitalized and not needing immediate capital raises [41][135] Question: How does the company view the impact of tariffs on development costs? - Tariffs could lead to a 2% to 6% increase in costs, but the company has secured contracts to mitigate risks [116] Question: What is the status of the West Cambridge development project? - The project is not yet fully entitled, with a focus on residential development first, and no immediate capital exposure for Healthpeak [123][128]

Calko Medical Building Brooklyn, NY Earnings Release and Supplemental Report First Quarter 2025 ___________________________________________________________________ To learn more about Healthpeak's commitment to responsible business and view our most recent Corporate Impact Report, please visit www.healthpeak.com/corporate-impact. Return to TOC 3 – Net income of $0.06 per share, Nareit FFO of $0.45 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.43 per share, and Total Same-Store Portfolio Cash (Ad ...

Core Viewpoint - Healthpeak Properties, Inc. reported first-quarter 2025 funds from operations (FFO) as adjusted per share of 46 cents, meeting expectations and showing a slight increase from 45 cents in the prior year, driven by better-than-anticipated revenues despite higher interest expenses [1][2]. Financial Performance - The company generated revenues of $702.9 million, exceeding the Zacks Consensus Estimate of $691.9 million, representing a year-over-year increase of 15.9% [2]. - Healthpeak reported a 7% year-over-year growth in total merger-combined same-store cash (adjusted) net operating income (NOI) [3]. - The outpatient medical and lab segments experienced year-over-year growth of 5% and 7.7%, respectively, while the Continuing Care Retirement Communities (CCRC) segment reported a growth of 15.9% [3]. Lease Activity - In the reported quarter, Healthpeak executed lab new and renewal leases totaling 276,000 square feet, achieving a retention rate of 88% and +5% cash-releasing spreads on renewals [4]. - For the outpatient medical portfolio, new and renewal leases totaled 973,000 square feet, with a retention rate of 86% and +4% cash-releasing spreads on renewals [4]. Balance Sheet - As of March 31, 2025, Healthpeak had cash and cash equivalents of $70.6 million, down from $119.8 million at the end of 2024, with a net debt to adjusted EBITDAre ratio of 5.2X [5]. - The company repurchased 5.1 million shares at a weighted average price of $18.50, totaling $94 million, from the beginning of the year through April 24 [5]. 2025 Outlook - Healthpeak reaffirmed its guidance for 2025, expecting FFO as adjusted per share to be between $1.81 and $1.87, with the Zacks Consensus Estimate at $1.85 [6]. - The company anticipates total merger-combined same-store cash (adjusted) NOI growth in the range of 3-4% for the year [6].